High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the european group for blood and marrow transplantation and the united kingdom lymphoma group

J. W. Sweetenham, G. Santini, W. Qian, M. Guelfi, N. Schmitz, S. Simnett, A. Nagler, H. Holte, S. Kvaloy, P. Bruzzi, A. H. Goldstone

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Fingerprint Dive into the research topics of 'High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the european group for blood and marrow transplantation and the united kingdom lymphoma group'. Together they form a unique fingerprint.

Medicine & Life Sciences